Drug intelligence / Profile preview

fluorine-18

Development stage
Unknown
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**Fluorine-18** is a radioactive isotope of fluorine used primarily as a radionuclide in nuclear medicine, especially in positron emission tomography (PET) imaging. It has a half-life of about 110 minutes and decays via positron emission (β+ decay), enabling it to be incorporated into a variety of radiopharmaceuticals for diagnostic purposes. Fluorine-18’s favorable physical properties allow the synthesis of PET radiotracers—most notably fluorodeoxyglucose (FDG)—for sensitive detection and monitoring of cancer, neurological disorders (like Alzheimer’s disease and epilepsy), cardiological conditions, and sites of infection or inflammation. Its ability to covalently bond to carbon makes it useful in developing many PET tracers, facilitating imaging of metabolic processes, receptor binding, and functional activity in tissues. Fluorine-18 tracers are produced in cyclotrons, usually by proton bombardment of ^18O-enriched water, and are supplied to hospitals or radiopharmacies for rapid radiolabeling and clinical use[2][4][5].

Other names
fluorine 18fluorine18fluorine-18F18F-18F 18^18F18F
02

Targets

SLC2A4 (Solute carrier family 2 facilitated glucose transporter member 4)GCK (Glucokinase)

Beyond the preview

Go deeper on fluorine-18.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluorine-18.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call